| Jul 16 |
Kymera Therapeutics: Solid Progress And No Change To My 'Buy' Rating
|
| Jul 14 |
XPeng & QuantumScape Are Among Top 11 Mid Cap Stocks That Performed Well Last Week (July 7-July 13): Details
|
| Jul 11 |
Biotech Stock Roundup: KYMR, IDYA, QURE Soar on Study Data, HLVX Tanks on Study Failure
|
| Jul 10 |
Kymera Therapeutics (KYMR) Surges 23.4%: Is This an Indication of Further Gains?
|
| Jul 9 |
Why Kymera Therapeutics Stock Is Soaring Today
|
| Jul 9 |
Kymera Therapeutics soars as Sanofi expands phase 2 trials
|
| Jul 9 |
Kymera Therapeutics Soars as Sanofi Expands Studies of Its Skin Diseases Drug
|
| Jul 9 |
Kymera's (KYMR) Partner SNY to Expand Ongoing HS and AD Studies
|
| Jul 9 |
Biggest stock movers today: BP, INTC, HELE, and more
|
| Jul 9 |
Kymera Therapeutics to Present in Fireside Chat at the UBS Virtual Targeted Protein Degradation Day
|
